Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer
Int. braz. j. urol; 44 (4), 2018
Publication year: 2018
ABSTRACT Objectives:
To evaluate the diagnostic performance of preoperative multiparametric magnetic resonance imaging (mp-MRI) as a predictor of extracapsular extension (ECE) and unfavorable Gleason score (GS) in patients with intermediate and high-risk prostate cancer (PCa).Materials and Methods:
Patients with clinically localized PCa who underwent radical prostatectomy (RP) and had preoperative mp-MRI between May-2011 and December-2013. Mp-MRI was evaluated according to the European Society of Urogenital Radiology MRI prostate guidelines by two different readers. Histopathological RP results were the standard reference.Results:
79 patients were included; mean age was 61 and median preoperative prostate-specific antigen (PSA) 7.0. On MRI, 28% patients had ECE evidenced in the mp-MRI, 5% seminal vesicle invasion (SVI) and 4% lymph node involvement (LNI). At RP, 39.2% had ECE, 26.6% SVI and 12.8% LNI. Sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of mp-MRI for ECE were 54.9%, 90.9%, 76%, 81% and 74.1% respectively; for SVI values were 19.1%, 100%, 77.3%, 100% and 76.1% respectively and for LNI 20%, 98.4%, 86.7%, 66.7% and 88.7%.Conclusions:
Major surgical decisions are made with digital rectal exam (DRE) and ultrasound studies before the use of Mp-MRI. This imaging study contributes to rule out gross extraprostatic extension (ECE, SVI, LNI) without competing with pathological studies. The specificity and NPV are reasonable to decide surgical approach. A highly experienced radiology team is needed to provide accurate estimations of tumor extension and aggressiveness.
Biopsia, Ganglios Linfáticos/diagnóstico por imagen, Ganglios Linfáticos/patología, Imagen por Resonancia Magnética/métodos, Persona de Mediana Edad, Clasificación del Tumor, Invasividad Neoplásica/patología, Estadificación de Neoplasias, Antígeno Prostático Específico/sangre, Prostatectomía/métodos, Neoplasias de la Próstata/diagnóstico por imagen, Neoplasias de la Próstata/patología, Neoplasias de la Próstata/cirugía, Reproducibilidad de los Resultados, Medición de Riesgo/métodos, Vesículas Seminales/diagnóstico por imagen, Vesículas Seminales/patología, Sensibilidad y Especificidad